Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Equillium, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 28 | 25 | −3 |
| Shares | 8.89M | 8.89M | −2.50K (0.0%) |
| Value | $20.5M | $6.15M | −$14.4M (−70.0%) |
New holders (5)
Institutions that held Equillium, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DCF Advisers, LLC | 32,962 | $22.8K | 0.01% |
| HRT Financial LP | 30,506 | $21.0K | 0.00% |
| Tritonpoint Wealth, LLC | 13,500 | $9.36K | 0.00% |
| UBS Group AG | 6,287 | $4.36K | 0.00% |
| Bank of America Corp | 158 | $109 | 0.00% |
Sold out (8)
Institutions that held Equillium, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Jane Street Group, LLC | 41,756 | $96.5K |
| American Century Companies Inc | 40,332 | $93.2K |
| Prudential Financial Inc | 31,200 | $72.1K |
| Prelude Capital Management, LLC | 15,500 | $35.8K |
| Marshall Wace, LLP | 11,897 | $27.5K |
| Ground Swell Capital, LLC | 11,433 | $26.4K |
| Tower Research Capital LLC (TRC) | 7,359 | $17.0K |
| Citadel Advisors LLC | 306 | $707 |